Back

Efficacy and safety of zilebesiran for inadequately controlled hypertension: a systematic review and meta-analysis

28 August 2026 (09:15 - 09:40)
Organised by: Logo
Congress Presentation Part of: Contemporary pharmacotherapy for hypertension Aldosterone Antagonists ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Thiago Bonafe

Varzea Grande (Brazil)

3 More presentations in this session

Presentation thumbnail
Risk of incident gout and major adverse cardiovascular events according to angiotensin receptor blocker type in amlodipine-based combination therapy: a nationwide cohort study
Assistant Professor S. Bae (Yongin, KR)
Abstract Slides Video
Presentation thumbnail
Female-biased renin release in response to relaxin in isolated rat renal cortex: potential implications for RAAS-mediated congestion with relaxin analogues
Professor M. Ufnal (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Comparative efficacy and safety of nebivolol in hypertension: a systematic review and network meta-analysis
Doctor D. Rammahy (Oakville, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Contemporary pharmacotherapy for hypertension

The Event

Event poster

ESC Congress 2026

28 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Zilebesiran in combination with a diuretic in patients with uncontrolled hypertension: a subgroup analysis from the Phase 2 KARDIA-3 trial
30 August 2026
thumbnail
Congress Presentation
Safety of potassium-binding agents in HFrEF: a meta-analysis of randomized trials
28 August 2026
thumbnail
Congress Presentation
Dose-response and efficacy ceiling of zilebesiran: a bayesian non-linear spline meta-analysis of phase 1 and KARDIA phase 2 trials
29 August 2026
thumbnail
Congress Presentation
RNA targeted therapies for lipoprotein(a) lowering: systematic review and meta analysis of siRNA and antisense oligonucleotides
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources